Eksigent has announced a new distribution agreement with Hong Kong-based Bionoetikos Ltd. The agreement covers sales and service of Eksigent’s NanoLC™ HPLC product line in Taiwan, Indonesia, Philippines, Vietnam, Malaysia, Singapore, Thailand, Laos and Cambodia.
Bionoetikos Ltd. is a life science industry consulting and distribution company focusing on Asia. The company has expertise in a range of applications including molecular biology, protein science, bioprocess engineering, agri-biotech, food and beverage and clinical diagnostics.
"We are delighted to work with Bionoetikos in these growing countries where researchers are hungry for new technology," commented David Weber, Eksigent’s President and CEO. "As our installed base grows in this part of the world, we also expect to see our systems used in some interesting new applications."
"The Bioneotikos group is pleased to work with Eksigent, whose technology is clearly a superior solution for front-end sample handling in LC-MS applications for proteomics," said Mark Daniels, managing director of Bionoetikos, Ltd.
"The need for advanced proteomics and other drug discovery technologies will continue to grow in Southeast Asia, where healthcare challenges and consciousness are on the rise. Agricultural research is also a critical field with the region’s huge and rising population," Daniels added.
Eksigent’s NanoLC-1D and NanoLC-2D proteomics systems incorporate microfluidic flow control technology to eliminate the need for flow splitting, resulting in reproducibility with minimal solvent waste.